Lymphoma
Non-Hodgkin’s Lymphoma, Large B-Cell
- SWOG S0806: Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
B-Cell Chronic Lymphocytic Leukemia or SLL
- PSOC 2401: A Phase I/II Study of Fludarabine, Cyclophosphamide Rituximab, and Vorinostat Followed by Rituximab and Vorinostat Maintenance Therapy in Patients with Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
Relapsed or Refractory Lymphoid Malignancies
- PSOC 2502: A Phase I Study of Bendamustine/Treanda, Rituximab, Etoposide and Carboplatin for Patients with Relapsed or Refractory Lymphoid Malignancies and Select Untreated Lymphomas
For more information, contact Cheryl Patz, RN, OCN, CCRC, at (360) 715-4133.
